Clara Lucato dos Santos

Dr. Clara Lucato dos Santos


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2024 in Clinics
Verified
Journal Article
Open access
CSClara Lucato dos Santos
Clara Lucato dos Santos
IBIndyanara Inacio Barreto
Indyanara Inacio Barreto
IFIdevaldo Floriano
Idevaldo Floriano
LTLuca Schiliró Tristão
Luca Schiliró Tristão
ASAntonio Silvinato
Antonio Silvinato
WBWanderley Bernardo
Wanderley Bernardo
Autism Spectrum Disorder (ASD) is a heterogeneous neurodevelopmental disorder, with main manifestations related to communication, social interaction, and behavioral patterns. The slight dynamics of change in the child over time require that the onset of clinical manifestations presented by the child be more valued, with the aim of stabilizing the condition. Faced with a variety of methods for diagnosing ASD, the question arises as to which method should be used. This systematic review aims to recommend the best tools to perform screening and diagnosis. This systematic review followed the PRISMA guidelines. The databases MEDLINE, Embase, CENTRAL (Cochrane), and Lilacs were accessed, and gray and manual searches were performed. The search strategy was created with terms referring to autism and the diagnosis/broad filter. The studies were qualitatively evaluated and quantitatively. Statistical analysis was performed using Meta-diSc-2.0 software, the confidence interval was 95 %. The M-CHAT-R/F tool demonstrated a sensitivity of 78 % (95 % CI 0.57‒0.91) and specificity of 0.98 (95 % CI 0.88-1.00). The diagnostic tools demonstrated sensitivity and specificity respectively of: ADOS, sensitivity of 87 % (95 % CI 0.79‒0.92) and specificity 75 % (95 % CI 0.73‒0.78); ADI-R demonstrated test sensitivity of 77 % (95 % CI 0.56‒0.90) and specificity 68 % (95 % CI 0.52‒0.81), CARS test sensitivity was 89 % (95 % CI 0.78‒0.95) and specificity 79 % (95 % CI 0.65‒0.88). It is mandatory to apply a screening test, the most recommended being the M-CHAT-R/F. For diagnosis CARS and ADOS are the most recommended tools.

11 June 2022 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
LDLetícia Nogueira Datrino
Letícia Nogueira Datrino
MOMarina Orlandini
Marina Orlandini
MSMaria Carolina Andrade Serafim
Maria Carolina Andrade Serafim
CSClara Lucato dos Santos
Clara Lucato dos Santos
VMVictoria Andrade Modesto
Victoria Andrade Modesto
Francisco TustumiFrancisco Tustumi
Francisco Tustumi

16 November 2024 in Cells
Verified
Journal Article
Open access
PDF file
DSDaniela Stols-Gonçalves
Daniela Stols-Gonçalves
AMAbraham S. Meijnikman
Abraham S. Meijnikman
LTLuca Schiliró Tristão
Luca Schiliró Tristão
CSClara Lucato dos Santos
Clara Lucato dos Santos
NDNerissa Denswil
Nerissa Denswil
MNmax Nieuwdorp
max Nieuwdorp
Background: Metabolic dysfunction-associated liver disease (MASLD) and alcohol-associated liver disease (ALD) are among the leading causes of liver disease worldwide. The exact roles of epigenetic factors in both diseases remains largely unknown. In this context, liver DNA methylation remains a field that requires further exploration and understanding. Methods: We performed a systematic review of liver DNA methylation in humans with MASLD or ALD using Ovid MEDLINE, Ovid Embase, and Cochrane Library. We included human studies where liver DNA methylation was assessed in patients with MASLD and/or ALD. The Rayyan platform was used to select studies. Risk of bias was assessed with the “risk of bias in non-randomized studies of interventions” tool, ROBINS-I. We performed pathway analysis using the most important differentially methylated genes selected in each article. Results: Fifteen articles were included in this systematic review. The risk of bias was moderate to serious in all articles and bias due to confounding and patient selection was high. Sixteen common pathways, containing differentially methylated genes, including cancer pathways, were identified in both diseases. Conclusions: There are common pathways, containing differentially methylated genes, in ALD and MASLD, such as pathways in cancer and peroxisome proliferator-activated receptor (PPAR) signaling pathways. In MASLD, the insulin signaling pathway is one of the most important, and in ALD, the MAPK signaling pathway is the most important. Our study adds one more piece to the puzzle of the mechanisms involved in steatotic liver disease.

26 December 2024 in Clinics
Verified
Journal Article
Open access
CSClara Lucato dos Santos
Clara Lucato dos Santos
IBIndyanara Inacio Barreto
Indyanara Inacio Barreto
ASAna Carolina Furian da Silva
Ana Carolina Furian da Silva
JSJuliana Firmino Batista Soriano
Juliana Firmino Batista Soriano
JCJeferson de Lima Silva Castro
Jeferson de Lima Silva Castro
WBWanderley Bernardo
Wanderley Bernardo
Autism Spectrum Disorder (ASD) is a neurodevelopment spectrum characterized by persistent deficits in social communication and interpersonal interaction, along with restricted and repetitive patterns of behavior, interest, or activities. The appropriate screening and diagnosis must be realized to improve the children's prognosis. Moreover, appropriate treatments are necessary to promote better social integration and development. In this scenario, this systematic review aims to evaluate the impacts of behavioral therapies applied in healthcare settings for patients with ASD. This systematic review followed the PRISMA guidelines. The databases MEDLINE, Embase, CENTRAL (Cochrane), and Lilacs were accessed, and gray and manual searches were performed. The search strategy was created with terms referring to autism and behavioral therapy. The studies were assessed qualitatively. Randomized clinical trials and observational studies demonstrated improvements in cognitive and verbal components of patients who received behavioral therapies in therapeutic settings. These results indicate a positive impact of both cognitive-behavioral therapy and ESDM on the development of patients' skills. Among the cognitive-behavioral therapies, the one based on the MASSI protocol did not impact the reduction of anxious symptoms. As for cognitive-behavioral therapy, one study demonstrated that the Behavioral Intervention for Anxiety in Children with Autism (BIACA), when compared to the Coping Cat protocol, improves cognition and reduces anxiety symptoms. Despite these results, further randomized clinical trials comparing behavioral therapies with one another are needed. In the context of behavioral therapy within a healthcare setting, the Early Start Denver Model (ESDM) showed improvements in the cognitive, verbal, and social aspects of the evaluated patients. Improvement in scores sometimes is achieved independently of the group and related to the time of interventions.

4 April 2024 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
EBEduardo L. S. Bastos
Eduardo L. S. Bastos
WJWilson Salgado Jr
Wilson Salgado Jr
ADAnna C. B. Dantas
Anna C. B. Dantas
TOTiago R. Onzi
Tiago R. Onzi
LSLyz B. Silva
Lyz B. Silva
F(For the Scientific Committee of the Brazilian Society of Bariatric and Metabolic Surgery (SBCBM)
For the Scientific Committee of the Brazilian Society of Bariatric and Metabolic Surgery (SBCBM)

1 January 2024 in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Verified
Journal Article
Open access
PDF file
TOTiago Rafael Onzi
Tiago Rafael Onzi
WJWilson Salgado Jr
Wilson Salgado Jr
EBEduardo Lemos de Souza Bastos
Eduardo Lemos de Souza Bastos
ADAnna Carolina Batista Dantas
Anna Carolina Batista Dantas
LSLyz Bezerra Silva
Lyz Bezerra Silva
MCMatheus Pedrotti Chavez
Matheus Pedrotti Chavez
BACKGROUND: One anastomosis gastric bypass (OAGB) has gained prominence in the search for better results in bariatric surgery. However, its efficacy and safety compared to Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) remain ill-defined. AIMS: To compare the efficacy and safety of OAGB relative to RYGB and SG in the treatment of obesity. METHODS: We systematically searched PubMed, EMBASE, Cochrane Library, Lilacs, and Google Scholar databases for randomized controlled trials comparing OAGB with RYGB or SG in the surgical approach to obesity. We pooled outcomes for body mass index, percentage of excess weight loss, type-2 diabetes mellitus remission, complications, and gastroesophageal reflux disease. Statistical analyses were performed with R software (version 4.2.3). RESULTS: Data on 854 patients were extracted from 11 randomized controlled trials, of which 422 (49.4%) were submitted to OAGB with mean follow-up ranging from six months to five years. The meta-analysis revealed a significantly higher percentage of excess weight loss at 1-year follow-up and a significantly lower body mass index at 5-year follow-up in OAGB patients. Conversely, rates of type-2 diabetes mellitus remission, complications, and gastroesophageal reflux disease were not significantly different between groups. The overall quality of evidence was considered very low. CONCLUSIONS: Our results corroborate the comparable efficacy of OAGB in relation to RYGB and SG in the treatment of obesity, maintaining no significant differences in type-2 diabetes mellitus remission, complications, and gastroesophageal reflux disease rates.